Wyeth Pulls Plug On Trubion Candidate In NHL
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms forge ahead with rheumatoid arthritis program.
You may also be interested in...
Who Stays, Who Goes? Tricky Guessing On Wyeth/Pfizer’s Keeper Deals
"Buyer beware" is more often "seller beware" in the case of takeovers such as Pfizer's proposed mega-grab of Wyeth
Who Stays, Who Goes? Tricky Guessing On Wyeth/Pfizer’s Keeper Deals
"Buyer beware" is more often "seller beware" in the case of takeovers such as Pfizer's proposed mega-grab of Wyeth
Repercussions Of A Merger: TRU-015 Potentially Up For Grabs
Change-of-control provision may return Phase IIb rheumatoid arthritis program to biotech developer. Would Pfizer pay (again) to be the partner?